[Strategic Combination Approaches in Cancer Immunotherapy]
1Dept. of Thoracic Oncology, National Cancer Center Hospital.
None:
Recent advances in immune checkpoint inhibitors(ICIs)have transformed cancer therapy, particularly in non‒small cell lung cancer. However, monotherapy achieves limited efficacy due to resistance and an immunosuppressive tumor microenvironment. Rational combination strategies‒chemotherapy, molecular targeted agents, dual checkpoint blockade, antibody‒drug conjugates(ADCs), and radiotherapy‒have shown promise in enhancing antitumor immunity. This review outlines the rationale and clinical evidence behind these combinations, emphasizing current challenges in biomarker development, immune‒related toxicity management, and optimal treatment sequencing for future personalized immunotherapy.
More Related Videos
Related Concept Videos
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Treatment Resistant Cancers


